HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carissa R Moore Selected Research

TNF Receptor-Associated Factor 3

2/2016Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.
2/2015Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms.
1/2015Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.
12/2014Transcriptomic profiling of splenic B lymphomas spontaneously developed in B cell-specific TRAF3-deficient mice.
9/2014Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes.
3/2014Expression and function of a novel isoform of Sox5 in malignant B cells.
10/2013N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carissa R Moore Research Topics

Disease

7Neoplasms (Cancer)
02/2016 - 10/2013
6Lymphoma (Lymphomas)
02/2016 - 10/2013
4Multiple Myeloma
02/2016 - 10/2013
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2016 - 02/2015
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2014 - 10/2013
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
02/2015
1Hodgkin Disease (Hodgkin's Disease)
02/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2015
1Inflammation (Inflammations)
01/2015

Drug/Important Bio-Agent (IBA)

7TNF Receptor-Associated Factor 3IBA
02/2016 - 10/2013
2N-benzyladriamycin-14-valerate (AD 198)IBA
02/2016 - 10/2013
2Proteins (Proteins, Gene)FDA Link
02/2015 - 03/2014
1oridoninIBA
02/2016
1Bortezomib (Velcade)FDA Link
02/2016
1Pharmaceutical PreparationsIBA
02/2016
1CateninsIBA
03/2014
1Protein Isoforms (Isoforms)IBA
03/2014
1Therapeutic UsesIBA
10/2013
13-ingenyl angelateIBA
10/2013

Therapy/Procedure

1Aftercare (After-Treatment)
09/2014